Abstract
Cancer cells are dependent on the system immune evasion for their survival and evolution. T lymphocyte antitumoral activities can be suppressed through the PD-1/PD-L1 pathway. Antibodies blocking these proteins have been widely used in clinical trials to treat Cancer in humans, and their expressions have been analyzed as prognostic and predictive biomarkers. Canine neoplasms also express …